Literature DB >> 9665493

Complete primary sequences of two lambda immunoglobulin light chains in myelomas with nonamyloid (Randall-type) light chain deposition disease.

C Decourt1, G Touchard, J L Preud'homme, R Vidal, H Beaufils, M C Diemert, M Cogné.   

Abstract

We herein report on the first two primary sequences (BOU and RAC) of monoclonal light chains of the lambda type responsible for nonamyloid lambda light chain deposition disease. Both patients were affected with severe forms of myeloma complicated with renal failure. The pathological presentation typically featured Congo red-negative deposits along tubular basement membranes but differed somewhat from the typical "Randall-type" kappa light chain deposition disease: they lacked the prominent glomerulosclerosis pattern often featuring nonamyloid kappa deposits and were associated with cylinders or myeloma casts. Both protein sequences were deduced from those of the corresponding complementary DNAs in the bone marrow plasma cells. For each chain, products of three independent amplifications by polymerase chain reaction were sequenced and found to be identical. BOU and RAC lambda mRNAs had a normal overall structure consisting of Vlambda2 segments rearranged to Jlambda2Clambda2 but displayed a number of unusual features within their primary sequences. These substitutions are likely responsible for changes in light chain conformation that promote their aggregation and deposition along renal tubule basement membranes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9665493      PMCID: PMC1852939          DOI: 10.1016/s0002-9440(10)65573-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

1.  Structure and expression of the human immunoglobulin lambda genes.

Authors:  T J Vasicek; P Leder
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

Review 2.  Structurally abnormal immunoglobulins in human immunoproliferative disorders.

Authors:  M Cogné; C Silvain; A A Khamlichi; J L Preud'homme
Journal:  Blood       Date:  1992-05-01       Impact factor: 22.113

3.  Primary structure of a monoclonal kappa chain in myeloma with light chain deposition disease.

Authors:  A A Khamlichi; P Aucouturier; C Silvain; M Bauwens; G Touchard; J L Preud'homme; F Nau; M Cogné
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

4.  Amino acid sequence of k Sci, the Bence Jones protein isolated from a patient with light chain deposition disease.

Authors:  V Bellotti; M Stoppini; G Merlini; M C Zapponi; M L Meloni; G Banfi; G Ferri
Journal:  Biochim Biophys Acta       Date:  1991-10-21

5.  Structure of a monoclonal kappa chain of the V kappa IV subgroup in the kidney and plasma cells in light chain deposition disease.

Authors:  M Cogné; J L Preud'homme; M Bauwens; G Touchard; P Aucouturier
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

6.  Characterization of renal amyloid derived from the variable region of the lambda light chain subgroup II.

Authors:  M M Picken; G Gallo; J Buxbaum; B Frangione
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

7.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

8.  Canonical structures for the hypervariable regions of immunoglobulins.

Authors:  C Chothia; A M Lesk
Journal:  J Mol Biol       Date:  1987-08-20       Impact factor: 5.469

9.  Light-chain deposition disease: its relation with AL-type amyloidosis.

Authors:  D Ganeval; L H Noël; J L Preud'homme; D Droz; J P Grünfeld
Journal:  Kidney Int       Date:  1984-07       Impact factor: 10.612

10.  Serologically defined V region subgroups of human lambda light chains.

Authors:  A Solomon; D T Weiss
Journal:  J Immunol       Date:  1987-08-01       Impact factor: 5.422

View more
  1 in total

1.  Somatic mutations of the L12a gene in V-kappa(1) light chain deposition disease: potential effects on aberrant protein conformation and deposition.

Authors:  R Vidal; F Goñi; F Stevens; P Aucouturier; A Kumar; B Frangione; J Ghiso; G Gallo
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.